PharmEasy

PharmEasy is among the top on-demand digital healthcare and e-pharmacy platform in India backed by its technology-enabled ecosystem offering delivery of medicines, diagnostic testing, teleconsultation and services across the healthcare spectrum. API Holdings — the parent of PharmEasy, which was founded in 2015 and is based out of Mumbai — has become a key player in India’s health-tech space making medicines and services more accesible across urban and semi-urban markets.

Its platform allows customers to order prescription drugs, schedule laboratory tests, avail of health packages, consult doctors online, and buy wellness and healthcare products via its mobile application and website. PharmEasy supply-chain and partner-pharmacy has a deep presence in all major parts of India enabling large-scale delivery, both for last-mile medicines and diagnostics. Apart from that, the company expanded its market further through the acquisition of Thyrocare, one among India's largest diagnostic chains — bringing a strong complement of capabilities to deeper integration between diagnostics and digital healthcare delivery.

PharmEasy has emerged as one of the most recognized startups in India’s health-tech space since its launch, with investors including Prosus, Temasek, TPG Growth and B Capital. It has also prioritized affordability, digital accessibility and healthcare access on par with the platforms like Tata 1mg, Apollo 24/7 and Netmeds. The valuation correction and delaying IPO plans were in reflection of larger trends affecting the startup market, but its still a tightly run machine with PharmEasy expanding its healthcare ecosystem and remaining a large part of India's fast growing online healthcare/pharmacy sector.